Merck Serono Signs Multiple Sclerosis Deal with Ambrx
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 2 (Table of Contents)
Published: 24 Feb-2009
DOI: 10.3833/pdr.v2009.i2.81 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Merck Serono has bought the rights to ARX424, an experimental multiple sclerosis drug, from Ambrx...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS